U.S. Stem Cell, Inc.【USRM】

時価総額

$6.4万

PER

再生医療・細胞療法の新興企業。1999年8月設立。MyoCellやAdipocell、医師向け研修・幹細胞キットを展開。2017年3月のNorthstar和解。2022年12月31日時点で現金5,133ドルの報告。米国中心の展開。

	2011年 12月31日	2015年 12月31日	2016年 12月31日	2017年 12月31日	2018年 12月31日	2020年 12月31日	2021年 12月31日	2022年 12月31日
Cash and cash equivalents	36,828	58,372	270,720	986,799	1	-	39,393	5,133
Accounts receivable, net of allowance of $75,000	3,495	35,032	16,025	42,959	18,035	-	1,213	4,332
Inventories	63,702	17,406	42,218	70,364	93,215	-	393	980
Prepaid expenses and other current assets	-	4,832	-	3,128	38,128	-	10,000	57,594
Total current assets	153,853	115,642	328,963	1	2	-	50,999	68,039
Total assets	268,493	229,113	427,636	2	2	-	50,999	68,039
Accounts payable	2	2	1	1	1	-	1	2
Accrued expenses	4	726,751	904,772	929,119	1	-	2	3
Advances - related parties	-	-	-	-	-	-	-	1
Contract liabilities, current portion	-	71,961	126,932	211,042	293,665	3,000	3,000	3,000
Deposits	465,286	465,286	465,286	465,286	465,286	-	465,286	465,286
Notes payable - related parties	-	-	-	-	-	-	-	4
Notes payable, current portion, net of debt discount of $10,515 and $10,052, respectively	-	-	-	-	-	-	3	3
Promissory note payable	-	608,502	680,336	1	462,330	-	1	1
Convertible notes payable, net of debt discount of $37,224 and $0, respectively	-	-	-	-	-	-	194,411	390,776
Total current liabilities	12	6	6	6	6	-	12	14
Contract liabilities	-	-	71,500	68,500	65,500	-	56,500	53,500
Notes payable, net of debt discount of $11,059 and $21,575, respectively	-	983,727	982,579	687,453	1	-	722,060	682,044
Total long-term liabilities	-	2	2	2	3	-	778,560	735,544
Total liabilities	12	8	8	9	9	-	13	15
Commitments and contingencies (See Note 11)	-	-	-	-	-	-	-	-
Preferred stock, par value $0.001; 20,000,000 shares authorized, -0- issued and outstanding	-	20,000	20,000	-	-	-	-	-
Common stock, par value $0.001; 2,000,000,000 shares authorized, 634,402,623 and 503,525,051 shares issued and outstanding, respectively	95,625	1,814	127,013	342,113	378,077	-	503,525	634,403
Additional paid-in capital	99	115	116	120	123	-	127	127
Accumulated deficit	-	-122,076,374	-124,146,760	-127,628,251	-129,788,678	-	-139,801,924	-142,517,282
Total stockholders' deficit	-12,010,477	-7,721,446	-8,018,644	-7,100,317	-6,882,210	-	-12,766,336	-14,745,396
Total liabilities and stockholders' deficit	268,493	229,113	427,636	2	2	-	50,999	68,039